Stockreport

RGNX's "Transformational" Promise Became a $2.40 Loss for Investors: Levi & Korsinsky, LLP

REGENXBIO Inc.  (RGNX) 
Last regenxbio inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.regenxbio.com
PDF NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) --  "Very promising results." That is how REGENXBIO, Inc. (NASDAQ: RGNX) characterized its RGX-111 gene therapy candidate as [Read more]